Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Bujar, Magdalena
16  Ergebnisse:
Personensuche X
?
1

The Qualitative Value of Facilitated Regulatory Pathways in..:

Bujar, Magdalena ; McAuslane, Neil ; Liberti, Lawrence
Pharmaceutical Medicine.  35 (2021)  2 - p. 113-122 , 2021
Link: https://doi.org/10.1007/..
 
?
2

Quality Decision-Making Practices in Pharmaceutical Compani..:

Bujar, Magdalena ; McAuslane, Neil ; Connelly, Patricia.
Therapeutic Innovation & Regulatory Science.  54 (2020)  6 - p. 1404-1415 , 2020
Link: https://doi.org/10.1007/..
 
?
3

Quality Decision Making in Health Technology Assessment: Is..:

Bujar, Magdalena ; McAuslane, Neil ; Walker, Stuart R..
Therapeutic Innovation & Regulatory Science.  54 (2020)  2 - p. 275-282 , 2020
Link: https://doi.org/10.1007/..
 
?
4

The Reliability and Relevance of a Quality of Decision Maki..:

Bujar, Magdalena ; McAuslane, Neil ; Walker, Stuart.
Frontiers in Pharmacology.  10 (2019)  - p. , 2019
Link: https://doi.org/10.3389/..
 
?
5

Quality Decision Making in Health Technology Assessment: Is..:

Bujar, Magdalena ; McAuslane, Neil ; Walker, Stuart R..
Therapeutic Innovation & Regulatory Science.  , 2019
Link: https://doi.org/10.1177/..
 
?
6

Evaluating Quality of Decision-Making Processes in Medicine..:

Bujar, Magdalena ; McAuslane, Neil ; Walker, Stuart R..
Frontiers in Pharmacology.  8 (2017)  - p. , 2017
Link: https://doi.org/10.3389/..
 
?
7

Assessing the Quality of Decision Making in the Development..:

Bujar, Magdalena ; Donelan, Ronan ; McAuslane, Neil..
Therapeutic Innovation & Regulatory Science.  51 (2017)  2 - p. 250-256 , 2017
Link: https://doi.org/10.1177/..
 
?
8

Quality of Regulatory Decision-Making Practices: Issues Fac..:

Bujar, Magdalena ; McAuslane, Neil ; Salek, Sam.
Therapeutic Innovation & Regulatory Science.  50 (2016)  4 - p. 487-495 , 2016
Link: https://doi.org/10.1177/..
 
?
9

The Qualitative Value of Facilitated Regulatory Pathways in..:

Bujar, Magdalena ; McAuslane, Neil ; Liberti, Lawrence
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858039/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
10

Quality Decision-Making Practices in Pharmaceutical Compani..:

Bujar, Magdalena ; McAuslane, Neil ; Connelly, Patricia.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704497/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
11

The Reliability and Relevance of a Quality of Decision Maki..:

Bujar, Magdalena ; McAuslane, Neil ; Walker, Stuart.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351444/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
12

Evaluating Quality of Decision-Making Processes in Medicine..:

Bujar, Magdalena ; McAuslane, Neil ; Walker, Stuart R.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385334/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
13

Development of a Roadmap and Evaluation of Quality Decision..:

Bujar, Magdalena Gabriela
http://hdl.handle.net/2299/20536.  , 2018
Link: http://hdl.handle.net/22..
 
?
14

A Process for Evaluating Quality Decision-Making Practices ..:

Magdalena Bujar ; Neil McAuslane ; Stuart Walker.
https://www.ijhpm.com/article_3832_df04017cfbe6c51c03f94f048ae45406.pdf.  , 2022
Link: https://doi.org/10.34172..
 
?
15

The Reliability and Relevance of a Quality of Decision Maki..:

Magdalena Bujar ; Neil McAuslane ; Stuart Walker.
https://www.frontiersin.org/article/10.3389/fphar.2019.00017/full.  , 2019
Link: https://doi.org/10.3389/..
 
1-15